The Bronchiectasis drugs in development market research report provides comprehensive information on the therapeutics under development for Bronchiectasis, complete with analysis by stage of ...

Electromed specializes in HFCWO therapy with its SmartVest System, targeting respiratory diseases. Find out my recommendation ...

Insmed Inc. (INSM) said it presented positive late-breaking subgroup data from the Phase 3 ASPEN study, a global, randomized, ...

The cathepsin C (CatC) inhibitor BI 1291583 is associated with a decreased risk for an exacerbation in adults with bronchiectasis, according to study findings published in the European Respiratory ...

Four-year-old Nathan Tasker, who lives with cerebral palsy, and other kids from across WA will be able to benefit from a $3.6 ...

Children were 50% more likely to be diagnosed with diabetes around six months after contracting the coronavirus infection ...

gmail.com Aim To determine whether a child with chronic wet cough and poor response to at least 4 weeks of oral antibiotics is more likely to have bronchiectasis. Methods All chest multi-detector ...

University of California San Diego and University of California Berkeley researchers have been awarded up to $7 million from ...

BRIDGEWATER, N.J. - Insmed (NASDAQ:INSM) Incorporated (NASDAQ:INSM), a global biopharmaceutical company, announced consistent positive results from its Phase 3 ASPEN study of brensocatib in treating ...

Insmed Inc (INSM) reports robust financial performance and outlines strategic initiatives for upcoming product launches amid ...